Serveur d'exploration SRAS - Analysis (2020)

Index « Titre (en) » - entrée « therapeutic »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
than < therapeutic < therapeutics  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 24.
[0-20] [0 - 20][0 - 24][20-23][20-40]
Ident.Authors (with country if any)Title
000055 (2020) J. Wang [République populaire de Chine] ; B J Wang [République populaire de Chine] ; J C Yang [République populaire de Chine] ; M Y Wang [République populaire de Chine] ; C. Chen [République populaire de Chine] ; G X Luo [République populaire de Chine] ; W F He [République populaire de Chine][Advances in the research of mechanism of pulmonary fibrosis induced by Corona Virus Disease 2019 and the corresponding therapeutic measures].
000110 (2020) Guangdi Li ; Erik De ClercqTherapeutic options for the 2019 novel coronavirus (2019-nCoV).
000111 (2020) Rohit Shetty [Inde] ; Arkasubhra Ghosh [Inde] ; Santosh G. Honavar [Inde] ; Pooja Khamar [Inde] ; Swaminathan Sethu [Inde]Therapeutic opportunities to manage COVID-19/SARS-CoV-2 infection: Present and future.
000112 (2020) Mansour Tobaiqy ; Mohammed Qashqary ; Shrooq Al-Dahery ; Alaa Mujallad ; Almonther Abdullah Hershan ; Mohammad Azhar Kamal [Arabie saoudite] ; Nawal Helmi [Arabie saoudite]Therapeutic Management of COVID-19 Patients: A systematic review
000184 (2020) Naidi Yang [République populaire de Chine] ; Han-Ming Shen [République populaire de Chine]Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19
000251 (2020) Shu-Ren Li [République populaire de Chine] ; Zi-Jian Tang [République populaire de Chine] ; Zai-Han Li [République populaire de Chine] ; Xuan Liu [République populaire de Chine]Searching therapeutic strategy of new coronavirus pneumonia from angiotensin-converting enzyme 2: the target of COVID-19 and SARS-CoV.
000356 (2020) Emmie De Wit ; Friederike Feldmann ; Jacqueline Cronin ; Robert Jordan ; Atsushi Okumura ; Tina Thomas ; Dana Scott ; Tomas Cihlar ; Heinz FeldmannProphylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection
000403 (2020) Francesco Di Pierro [Oman] ; Alexander Bertuccioli [Italie] ; Ilaria Cavecchia [Italie]Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus.
000415 (2020) Laure Elens [Belgique] ; Loralie J. Langman [États-Unis] ; Dennis A. Hesselink [Pays-Bas] ; Stein Bergan [Norvège] ; Dirk Jan A R. Moes [Pays-Bas] ; Mariadelfina Molinaro [Italie] ; Raman Venkataramanan [États-Unis] ; Florian Lemaitre [France]Pharmacologic treatment of transplant recipients infected with SARS-CoV-2: considerations regarding therapeutic drug monitoring and drug-drug interactions.
000417 (2020) Guangyu Zhou [République populaire de Chine] ; Qi Zhao [République populaire de Chine]Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2
000418 (2020) Balamurugan Shanmugaraj [Thaïlande] ; Konlavat Siriwattananon [Thaïlande] ; Kittikhun Wangkanont [Thaïlande] ; Waranyoo Phoolcharoen [Thaïlande]Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19).
000424 (2020) Yong-Jian Geng [États-Unis] ; Zhi-Yao Wei [République populaire de Chine] ; Hai-Yan Qian [République populaire de Chine] ; Ji Huang [République populaire de Chine] ; Robert Lodato [États-Unis] ; Richard J. Castriotta [États-Unis]Pathophysiological Characteristics and Therapeutic Approaches for Pulmonary Injury and Cardiovascular Complications of Coronavirus Disease 2019
000552 (2020) Amin Gasmi [France] ; Sadaf Noor [Pakistan] ; Torsak Tippairote [Thaïlande] ; Maryam Dadar [Iran] ; Alain Menzel [France] ; Geir Bj Rklund [Norvège]Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic
000559 (2020) Bhumi Shah [Inde] ; Palmi Modi [Inde] ; Sneha R. Sagar [Inde]In silico studies on therapeutic agents for COVID-19: Drug repurposing approach.
000714 (2020) Azar Hadadi [Iran] ; Masoud Mortezazadeh [Iran] ; Kasra Kolahdouzan [Iran] ; Golbarg Alavian [Iran]Does recombinant human Erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects?
000766 (2020) Daniel J. Drucker [Canada]Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications.
000799 (2020) Miguel Angel Martinez [Espagne]Compounds with therapeutic potential against novel respiratory 2019 coronavirus.
000902 (2020) Kam Wa Chan [Hong Kong] ; Vivian Taam Wong [Hong Kong] ; Sydney Chi Wai Tang [Hong Kong]COVID-19: An Update on the Epidemiological, Clinical, Preventive and Therapeutic Evidence and Guidelines of Integrative Chinese-Western Medicine for the Management of 2019 Novel Coronavirus Disease.
000931 (2020) Deepak Atri [États-Unis] ; Hasan K. Siddiqi [États-Unis] ; Joshua Lang [États-Unis] ; Victor Nauffal [États-Unis] ; David A. Morrow [États-Unis] ; Erin A. Bohula [États-Unis]COVID-19 for the Cardiologist: A Current Review of the Virology, Clinical Epidemiology, Cardiac and Other Clinical Manifestations and Potential Therapeutic Strategies.
000942 (2020) Gong Feng [République populaire de Chine] ; Kenneth I. Zheng [République populaire de Chine] ; Qin-Qin Yan [République populaire de Chine] ; Rafael S. Rios [République populaire de Chine] ; Giovanni Targher [Italie] ; Christopher D. Byrne [Royaume-Uni] ; Sven Van Poucke [Belgique] ; Wen-Yue Liu [République populaire de Chine] ; Ming-Hua Zheng [République populaire de Chine]COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies
000953 (2020) B. RobsonCOVID-19 Coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed achilles’ heel conserved region to minimize probability of escape mutations and drug resistance

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i -k "therapeutic" 
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i  \
                -Sk "therapeutic" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    Title.i
   |clé=    therapeutic
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021